R-CHOP compared to R-CHOP + X for newly diagnosed diffuse large B-cell lymphoma: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

R-CHOP compared to R-CHOP + X for newly diagnosed diffuse large B-cell lymphoma: a systematic review and meta-analysis

Published:2021-03-18 Issue:6 Volume:60 Page:744-749
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Pasvolsky Oren¹²^ORCID,Rozental Alon¹²,Raanani Pia¹²,Gafter-Gvili Anat¹²³,Gurion Ronit¹²

Affiliation:

1. Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel

2. Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

3. Medicine A, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2021.1898048

Reference28 articles.

1. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

2. The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

3. Tailoring front-line therapy in diffuse large B-cell lymphoma: who should we treat differently?

4. Frontline treatment of diffuse large B‐cell lymphoma: Beyond R‐CHOP

5. Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicted survival of patients with human immunodeficiency virus-associated non-Hodgkin’s lymphoma based on clinical and imaging factors: A multicenter retrospective study;Radiology of Infectious Diseases;2023-09

2. A novel prednisone premedication protocol significantly decreases infusion‑related reactions of rituximab in newly diagnosed diffuse large B‑cell lymphoma;Oncology Letters;2023-04-28

3. Superiority of polatuzumab vedotin over other novel agents in previously untreated ABC-type diffuse large B-cell lymphoma: a network meta-analysis of 20 RCTs;Annals of Hematology;2023-03-22

4. Comparison of first-line treatments for elderly patients with diffuse large B-cell lymphoma: A systematic review and network meta-analysis;Frontiers in Immunology;2023-01-04

5. The Endothelial Activation and Stress Index (EASIX) score is an independent prognostic factor in patients with diffuse large B-cell lymphoma;BMC Cancer;2022-07-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3